Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: Diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol

Critical Care Medicine

Volumn 31, Issue 5, 2003, Pages 1382-1388

  Marx, Christian ^a   Petros, Sirak ^b   Bornstein, Stefan R ^c   Weise, Matthias ^a   Wendt, Matthias ^a   Menschikowski, Mario ^a   Engelmann, Lothar ^b   Höffken, Gert ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Age; Androgen; Endocrine; Hypothalamic pituitaryadrenal axis; Immune; Inflammation

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGE; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS;

ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; AGED; APACHE; C-REACTIVE PROTEIN; CALCITONIN; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK FACTORS; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037906146     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000063282.83188.3D     Document Type: Article

References (42)

1. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332:1351-1362
2. Marx C, Ehrhart-Bornstein M, Scherbaum WA, et al: Regulation of adrenocortical function by cytokines: Relevance for immune-endocrine interaction. Horm Metab Res 1998; 30:416-420
3. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind single-center study. Crit Care Med 1999; 27:723-732
4. Oppert M, Reinicke A, Gräf KJ, et al: Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000; 26:1747-1755
5. Meduri GU: New rationale for glucocorticoid treatment in septic shock. J Chemother 1999; 11:541-550.
6. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
7. Koo DJ, Jackman D, Chaudry IH, et al: Adrenal insufficiency during late state of polymicrobial sepsis. Crit Care Med 2001; 29:618-622
8. Zaloga GP: Sepsis induced adrenal deficiency syndrome. Crit Care Med 2001; 29:671-696
9. Vermeulen A, Rubens R: Adrenal virilism. In: The Adrenal Gland. James VHT (Ed). New York, NY, Raven Press, 1992
10. Ducharme JR, Forest MG, De Peretti E, et al: Plasma adrenal and gonadal sex steroids in human pubertal development. J Clin Endocrinol Metab 1976; 42:468-476
11. de Peretti E, Forest MG: Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human: The use of a sensitive radioimmunoassay. J Clin Endocrinol Metab 1976; 43:982-991
12. Labrie F, Belanger A, Cusan L, et al: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82:2396-2402
13. Straub RH, Konecna L, Hrach S, et al: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are inversely correlated with serum interleukin-6 (IL-6), and DHEA inhibits [L-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83:2012-2017
14. Luppa P, Munker R, Nagel D, et al: Serum androgens in intensive-care patients: Correlations with clinical findings. Clin Endocrinol (Oxf) 1991; 34:305-310
15. Mulder JW, Frissen PH, Krijnen P, et al: Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic HIV-infected men. J Infect Dis 1992; 165:413-418
16. Piedrola G, Casado JL, Lopez E, et al: Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol 1996; 45:97-101
17. de la Torre B, von Krogh G, Svensson M, et al: Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels and CD4 T cell counts in HIV infection. Clin Exp Rheumatol 1997; 15:87-90
18. Suzuki T, Suzuki N, Daynes RA, et al: Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991; 61:202-211
19. McLachlan JA, Serkin CD, Bakouche O: Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol 1996; 156:328-335
20. Delpedro AD, Barjavel MJ, Mamdouh Z, et al: Activation of human monocytes by LPS and DHEA. J Interferon Cytokine Res 1998; 18:125-135
21. Schmidt M, Kreutz M, Loffler G, et al: Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 2000; 164:161-169
22. Padgett DA, Loria RM: In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol 1994; 153:1544-1552
23. Khorram O, Vu L, Yen SS: Activation of immune function by DHEA in age-advanced men. Gerontol A Biol Sci Med Sci 1997; 52:M1-M7
24. Rook GAW, Hernandez-Pando R, Lightman SL: Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15:301-303
25. Dhabhar FS, McEwen BS: Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci 1999; 96:1059-1064
26. Galon J, Franchimont D, Hiroi N, et al: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16:61-71
27. Maurer M, Trajanoski Z, Frey G, et al: Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. Hormone Metab Res 2002; 33:691-695
28. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
29. Sprung CL, Caralis PV, Marcial EH, et al: High-dose corticosteroids in patients with septic shock. N Engl J Med 1994; 311:1137-1143
30. Bone RC, Fisher CJ Jr, Clemmer TP, et al: A controlled trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
31. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiological doses of hydrocortisone. Crit Care Med 1998; 26:645-650
32. Arlt W, Callies F, van Vlijmen JC, et al: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341:1013-1020
33. Schroeder S, Wichers M, Klingmüller D, et al: The hypothalamic pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing-hormone. Crit Care Med 2001; 29:310-316
34. Bornstein SR, Chrousos GP: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs. J Clin Endocrinol Metab 1999; 84:1729-1736
35. Marx C, Höffken G, Petros S: Intra-adrenal regulation of adrenocortical function during severe sepsis. Crit Care Med 2002; 30:1937-38
36. Cutulo M, Foppiani L, Prete C, et al: Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26:247-250
37. Wolkersdörfer GW, Lohmann T, Marx C, et al: Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: A novel mechanism of immune-endocrine interaction. J Clin Endocrinol Metab 1999; 84:4220-4227
38. Bornstein SR, Wolkersdörfer GW, Tauchnitz R, et al: Plasma dehydroepiandrosterone levels during experimental endotoxemia and anti-inflammatory therapy in humans. Crit Care Med 2000; 28:2103-2106
39. Hennebold JD, Daynes RA: Regulation of dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. J Clin Endocrinol Metab 1994; 135:67-75
40. Angele MK, Catania RA, Ayala A, et al: Sepsis following trauma-induced hemorrhage. Arch Surgery 1998; 133:1281-1288
41. Oberbeck R, Dahlweid M, Koch R, et al: Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001; 29:380-384
42. Elenkov IJ, Papanicolaou DA, Wilder RL, et al: Effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Implications for the effect of stress on immunity and the Th1/Th2 balance. Proc Am Assoc Physicians 1996; 108:374-381